Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Discovery of the first potent and selective small molecule opioid receptor-like (ORL1) antagonist: 1-[(3R,4R)-1-cyclooctylmethyl-3- hydroxymethyl-4-piperidyl]-3-ethyl-1, 3-dihydro-2H-benzimidazol-2-one (J-113397).

× No keyword cloud information.

50 in total

1. Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence.

Authors: H Ueda; M Inoue; H Takeshima; Y Iwasawa
Journal: J Neurosci Date: 2000-10-15 Impact factor: 6.167

2. Inhibition of striatal and retinal dopamine release via nociceptin/orphanin FQ receptors.

Authors: K Flau; A Redmer; S Liedtke; M Kathmann; E Schlicker
Journal: Br J Pharmacol Date: 2002-12 Impact factor: 8.739

Review 3. Nociceptin Opioid Receptor (NOP) as a Therapeutic Target: Progress in Translation from Preclinical Research to Clinical Utility.

Authors: Nurulain T Zaveri
Journal: J Med Chem Date: 2016-03-14 Impact factor: 7.446

4. Presynaptic opioid receptors on noradrenergic and serotonergic neurons in the human as compared to the rat neocortex.

Authors: Benjamin Berger; Anna Katharina Rothmaier; Franziska Wedekind; Josef Zentner; Thomas J Feuerstein; Rolf Jackisch
Journal: Br J Pharmacol Date: 2006-06-05 Impact factor: 8.739

5. A new synthesis of the ORL-1 antagonist 1-[(3R,4R)-1-cyclooctylmethyl-3-hydroxymethyl-4-piperidinyl]-3-ethyl-1,3-dihydro-2H-benzimidazol-2-one (J-113397) and activity in a calcium mobilization assay.

Authors: Emilie D Smith; N Ariane Vinson; Desong Zhong; Bertold D Berrang; Jennifer L Catanzaro; James B Thomas; Hernán A Navarro; Brian P Gilmour; Jeffrey Deschamps; F Ivy Carroll
Journal: Bioorg Med Chem Date: 2007-10-13 Impact factor: 3.641

6. In silico study of the structurally similar ORL1 receptor agonist and antagonist pairs reveal possible mechanism of receptor activation.

Authors: Milan Senćanski; Ljiljana Dosen-Mićović
Journal: Protein J Date: 2014-06 Impact factor: 2.371

7. The design and synthesis of a novel quinolizidine template for potent opioid and opioid receptor-like (ORL1, NOP) receptor ligands.

Authors: Ling Jong; Nurulain Zaveri; Lawrence Toll
Journal: Bioorg Med Chem Lett Date: 2004-01-05 Impact factor: 2.823

8. Buprenorphine: a unique drug with complex pharmacology.

Authors: Kabirullah Lutfy; Alan Cowan
Journal: Curr Neuropharmacol Date: 2004-10 Impact factor: 7.363

Review 9. Nociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.

Authors: Lawrence Toll; Michael R Bruchas; Girolamo Calo'; Brian M Cox; Nurulain T Zaveri
Journal: Pharmacol Rev Date: 2016-03-08 Impact factor: 25.468

10. Buprenorphine reduces alcohol drinking through activation of the nociceptin/orphanin FQ-NOP receptor system.

Authors: Roberto Ciccocioppo; Daina Economidou; Roberto Rimondini; Wolfgang Sommer; Maurizio Massi; Markus Heilig
Journal: Biol Psychiatry Date: 2006-03-14 Impact factor: 13.382